CEWG Steering Committee
Anna D. Barker, PhD, FAACR
(2023-2025)Chief Strategy Officer
Lawrence J. Ellison Institute for Transformative Medicine
University of Southern California
Los Angeles, California
Jeffrey P. Townsend, PhD
(2023-2025)Elihu Professor of Biostatistics
Professor of Ecology and Evolutionary Biology
Yale School of Public Health
New Haven, Connecticut
Frank H. Laukien, PhD
(2024-2025)Chairman, President and CEO
Bruker Corporation
Billerica, Massachusetts
Member, The Oncology Think Tank;
Visiting Scholar, Department of Chemistry and Chemical Biology
Harvard University
Cambridge, Massachusetts
Charles Swanton, MBPhD, FAACR
(2024-2025)Royal Society Napier Professor
The Francis Crick Institute and UCL Cancer Institute
Cancer Evolution and Genome Instability Laboratory
The Francis Crick Institute and UCL Cancer Institute
London, United Kingdom
Antonio Baines, PhD
(2024-2027)Associate Professor
Department of Biological & Biomedical Sciences
Cancer Research Program
JLC-Biomedical/Biotechnology Research Institute
Adjunct Associate Professor
Department of Pharmacology
School of Medicine
Member
Curriculum in Toxicology and Environmental Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Christina Curtis, PhD, MSc
(2021-2026)Professor of Medicine, Genetics and Biomedical Data Science
Director, Artificial Intelligence and Cancer Genomics
Director, Breast Cancer Translational Research
Stanford Cancer Institute
Stanford, California
James V. DeGregori, PhD
(2021-2026)Professor, Department of Biochemistry and Molecular Genetics
University of Colorado School of Medicine
Aurora, Colorado
Gad Getz, PhD, FAACR
(2024-2027)Director
Cancer Genome Analysis
The Broad Institute of MIT and Harvard
Krantz Family Center for Cancer Research
Department of Pathology
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
Jinsong Liu, MD, PhD
(2024-2027)Professor
Departments of Anatomic Pathology and Molecular Cellular Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas
Carlo C. Maley, PhD
(2021-2025)Director, Arizona Cancer and Evolution Center;
Associate Professor, Biodesign Institute and School of Life Sciences
Arizona State University
Tempe, Arizona
Andriy Marusyk, PhD
(2021-2026)Associate Professor
Department of Cancer Physiology
Moffitt Cancer Center
Tampa, Florida
Franziska Michor, PhD
(2021-2025)Professor of Computational Biology
Departments of Data Sciences, Biostatistics, and Stem Cell and Regenerative Biology
Dana-Farber Cancer Institute
Harvard T.H. Chan School of Public Health, Harvard University
Boston, Massachusetts
Larry Norton, MD, FAACR
(2021-2026)Department Physician-In-Chief
Breast Cancer Program
Memorial Sloan Kettering Cancer Center
New York, New York
Eileen M. O’Reilly, MD
(2024-2027)Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head
Hepatopancreaticobiliary & Neuroendocrine Cancers
Co-director Medical Initiatives
David M. Rubenstein Center for Pancreatic Cancer
Chair
Human Research Protection Program & IRB
Attending Physician
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, New York
Kenneth J. Pienta, MD
(2021-2025)The Donald S. Coffey Professor of Urology
Professor of Oncology, Pharmacology, and Molecular Sciences
Johns Hopkins University School of Medicine
Baltimore, Maryland
George H. Poste, DVM, PhD, FRCPath, FmedSci, CBE, FRS
(2021-2025)Director and Chief Scientist, Complex Adaptive Systems Initiative
Regents’ Professor and Del E. Webb Professor of Health Innovation
Arizona State University
Tempe, Arizona
Susan M. Rosenberg, PhD
(2021-2025)Ben F. Love Chair in Cancer Research
Leader, Mechanisms in Cancer Evolution Program
Professor of Molecular and Human Genetics, Biochemistry and Molecular Biology, Molecular Virology and Microbiology, Integrative Molecular and Biomedical Sciences, Translational Biology, and Molecular Medicine
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas
Jason A. Somarelli, PhD
(2021-2026)Assistant Professor of Medicine
Director of Research
Duke Comparative Oncology Group
Duke Cancer Institute
Durham, North Carolina
Louis Vermeulen, MD, PhD
(2024-2027)Vice President
Discovery Oncology
Genentech Inc.
Professor of Molecular Oncology
LEXOR Department
Amsterdam UMC Cancer Center
Amsterdam, The Netherlands